Table 2.
Items | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Study | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Total Score* |
Barroso et al 34 | + | + | − | + | − | − | − | + | − | + | + | 5 |
Bertani et al 21 | + | + | − | − | − | − | − | + | − | + | + | 4 |
Blumenthal et al 22 | + | + | − | + | − | − | − | − | + | + | + | 5 |
Blumenthal et al 23 | + | + | − | + | − | − | − | + | − | + | + | 5 |
Brito et al 44 | + | + | − | + | − | − | − | + | − | + | + | 5 |
Dimeo et al 30 | + | + | − | + | − | − | − | + | − | + | + | 5 |
Farah et al 26 | + | + | + | + | − | − | + | − | − | + | + | 6 |
Guimaraes et al 33 | + | + | − | + | − | − | + | − | − | + | + | 5 |
Guimaraes et al 28 | + | + | + | − | − | + | − | − | + | + | 5 | |
Lima et al 24 | + | + | − | + | − | − | − | + | − | + | + | 5 |
Molmen‐Hansen et al 49 | + | + | − | + | − | − | − | − | − | + | + | 4 |
Motlagh et al 20 | + | + | + | + | − | − | − | − | + | + | + | 6 |
Pagonas et al 29 | + | + | − | + | − | − | − | + | − | + | + | 5 |
Stiller‐Moldovan et al 32 | + | + | + | + | − | − | − | − | − | − | + | 4 |
Westhoff et al 31 | + | + | − | − | − | − | − | + | − | + | + | 4 |
Column numbers correspond to the following criteria on the PEDro scale: (1) eligibility criteria were specified; (2) subjects were randomly allocated to groups; (3) allocation was concealed; (4) groups were similar at baseline; (5) subjects were blinded; (6) therapists who administered the treatment were blinded; (7) assessors were blinded; (8) measures of key outcomes were obtained from >85% of subjects; (9) data were analyzed by intention to treat; (10) statistical comparisons between groups were conducted; (11) point measures and measures of variability were provided.
Total score from item 2.